Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin

Contributed by: Business Wire

Logo

Tags

Health

Other Health

General Health

Clinical Trials

Research

Science

Pharmaceutical

Galderma SA

More Like This

EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch

Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity

Galderma Takes the ‘Face of Cetaphil®’ to the Runway at New York Fashion Week

Galderma Reaffirms Its Leadership in Dermatology With Extensive Presence at EADV 2024

Stigmatisation a major impact of skin diseases across Europe, reveals JEADV study

AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs

Galderma Launches ‘NEXT’, a Ground-Breaking Trend Report That Unveils the Future of Aesthetics

AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community